Corbus Pharmaceuticals Holdings (CRBP) Other Accumulated Expenses (2014 - 2021)

Corbus Pharmaceuticals Holdings' Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $1.7 million for Q4 2021.

• In Q4 2021, Other Accumulated Expenses rose 19.02% year-over-year to $1.7 million; the TTM figure through Dec 2021 stood at $1.7 million (up 19.02% YoY), while the FY2021 annual figure was $1.7 million, up 19.02% from the prior year.
• Other Accumulated Expenses for Q4 2021 stood at $1.7 million, up from $1.4 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $1.7 million in Q4 2021, with the low at $110446.0 in Q2 2017.
• The 5-year median for Other Accumulated Expenses is $953206.0 (2019), against an average of $921957.2.
• The sharpest annual moves came in 2019 and 2021: Other Accumulated Expenses soared 440.34% in 2019, then fell 16.06% in 2021.
• Corbus Pharmaceuticals Holdings' Other Accumulated Expenses stood at $146609.0 in 2017, then jumped by 214.17% to $460596.0 in 2018, then soared by 108.19% to $958928.0 in 2019, then soared by 52.35% to $1.5 million in 2020, then gained by 19.02% to $1.7 million in 2021.
• Business Quant data shows CRBP's Other Accumulated Expenses at $1.7 million in Q4 2021, $1.4 million in Q3 2021, and $1.5 million in Q2 2021.